Pharsight

Drugs that contain Doravirine

1. Pifeltro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8486975 MSD MERCK CO Non-nucleoside reverse transcriptase inhibitors
Oct, 2031

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) Jan 27, 2025

Market Authorisation Date: 30 August, 2018

Treatment: For use in combination with other antiretroviral agents for the treatment of hiv-1 as a replacement therapy in virologically suppressed adults with no history of treatment failure and no known substit...

Dosage: TABLET;ORAL

More Information on Dosage

PIFELTRO family patents

Family Patents